Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United State ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

Penumbra announced that it has launched the Element vascular access system, a laser-cut hypotube sheath designed for treating ...

AngioDynamics, Inc. announced the commencement of the AMBITION BTK multicenter randomized controlled trial (RCT), which will ...

Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (PIVL) platform for the treatment of ...

Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t ...

In a multicenter, retrospective review of patients admitted with intact and ruptured abdominal aortic aneurysms (AAAs), ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...

Surmodics, Inc. announced the early clinical use of its Pounce XL thrombectomy system, which is currently in limited market rel ...

The American Stroke Association (ASA) announced the presentation of the DISTAL study, which is investigating whether endovascul ...

Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...